Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
EspaƱol
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Badgett, James
(PI)
Pediatrics
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Down Syndrome
100%
Cytarabine
100%
Arm
50%
High Risk Population
25%
Liposomal Daunorubicin
25%
Event Free Survival
25%
Infusion
25%
Continuous Infusion
25%
Interim Analysis
25%
Tioguanine
25%
Etoposide
25%
Oral
25%
Pharmacology, Toxicology and Pharmaceutical Science
Down Syndrome
100%
Cytarabine
100%
Acute Myeloid Leukemia
100%
Elimination
25%
Event Free Survival
25%
Etoposide
25%
Tioguanine
25%
Daunorubicin
25%